Actinium Pharmaceuticals
(NYSEMKT) ATNM
Actinium Pharmaceuticals Financials at a Glance
Market Cap
$30.76M
Revenue (TTM)
$90.00K
Net Income (TTM)
$33.89M
EPS (TTM)
$-1.09
P/E Ratio
-0.90
Dividend
$0.00
Beta (Volatility)
1.42 (Average)
Dividend
$0.00
Beta (Volatility)
1.42 (Average)
Price
$0.99
Volume
122
Open
$1.00
Price
$0.99
Volume
122
Open
$1.00
Previous Close
$0.99
Daily Range
$0.99 - $1.00
52-Week Range
$0.95 - $1.95
Dividend
$0.00
Beta (Volatility)
1.42 (Average)
Price
$0.99
Volume
122
Open
$1.00
Previous Close
$0.99
Daily Range
$0.99 - $1.00
52-Week Range
$0.95 - $1.95
ATNM News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Actinium Pharmaceuticals
Industry
Biotechnology
Sector
Health CareEmployees
25
CEO
Sandesh Seth, MBA
Website
www.actiniumpharma.comHeadquarters
New York City, NY 10016, US
ATNM Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
-403%
Net Income Margin
-377%
Return on Equity
-167%
Return on Capital
-83%
Return on Assets
-65%
Earnings Yield
-1.11%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$30.76M
Shares Outstanding
31.38M
Volume
122
Short Interest
0.00%
Avg. Volume
120.51K
Financials (TTM)
Gross Profit
$90.00K
Operating Income
$36.25M
EBITDA
$35.43M
Operating Cash Flow
$24.58M
Capital Expenditure
$104.00K
Free Cash Flow
$24.68M
Cash & ST Invst.
$48.00M
Total Debt
$1.69M
Actinium Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$615.00K
+401.5%
Gross Margin
0.00%
N/A
Market Cap
$30.76M
N/A
Market Cap/Employee
$992.26K
N/A
Employees
31
N/A
Net Income
$5.94M
+10.7%
EBITDA
$8.91M
-38.3%
Quarterly Fundamentals
Net Cash
$46.30M
-35.1%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$972.00K
-2.1%
Short Term Debt
$722.00K
+24.5%
Return on Assets
-65.45%
N/A
Return on Invested Capital
-82.74%
N/A
Free Cash Flow
$5.39M
+6.2%
Operating Cash Flow
$5.29M
+8.0%